Published in Am J Psychiatry on April 01, 2014
Keep off the grass? Cannabis, cognition and addiction. Nat Rev Neurosci (2016) 1.01
Different Paths to Core Pathology: The Equifinal Model of the Schizophrenia Syndrome. Schizophr Bull (2015) 0.79
Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats. Psychopharmacology (Berl) (2015) 0.78
Converging models of schizophrenia - Network alterations of prefrontal cortex underlying cognitive impairments. Prog Neurobiol (2015) 0.76
The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia. Biol Psychiatry (2015) 0.76
Adolescent cannabis use, change in neurocognitive function, and high-school graduation: A longitudinal study from early adolescence to young adulthood. Dev Psychopathol (2016) 0.75
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males. Transl Psychiatry (2016) 0.75
Cannabinoid Modulation of Memory Consolidation in Rats: Beyond the Role of Cannabinoid Receptor Subtype 1. Front Pharmacol (2017) 0.75
Marijuana and adolescence: what can we learn from primates? Am J Psychiatry (2014) 0.75
Effects of Adolescent Cannabinoid Self-Administration in Rats on Addiction-Related Behaviors and Working Memory. Neuropsychopharmacology (2016) 0.75
Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A (2004) 17.86
Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA (2002) 6.48
Persistent cannabis users show neuropsychological decline from childhood to midlife. Proc Natl Acad Sci U S A (2012) 5.67
The effects of adolescent cannabis use on educational attainment: a review. Addiction (2000) 4.32
The residual cognitive effects of heavy marijuana use in college students. JAMA (1996) 4.28
Dissociation of object and spatial processing domains in primate prefrontal cortex. Science (1993) 4.15
Mapping brain maturation and cognitive development during adolescence. Trends Cogn Sci (2005) 3.93
Cannabis use and later life outcomes. Addiction (2008) 3.30
Neuropsychological performance in long-term cannabis users. Arch Gen Psychiatry (2001) 3.27
What has fMRI told us about the development of cognitive control through adolescence? Brain Cogn (2009) 3.08
Static and dynamic cognitive deficits in childhood preceding adult schizophrenia: a 30-year study. Am J Psychiatry (2010) 3.05
Developmental neurobiology of cognitive control and motivational systems. Curr Opin Neurobiol (2010) 2.86
Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend (2003) 2.68
Limbic lesions and the problem of stimulus--reinforcement associations. Exp Neurol (1972) 2.65
Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study: naturalistic study [corrected]. Br J Psychiatry (2010) 2.08
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Cognitive and subjective dose-response effects of acute oral Delta 9-tetrahydrocannabinol (THC) in infrequent cannabis users. Psychopharmacology (Berl) (2002) 1.84
The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev (2008) 1.78
Non-spatial memory after selective prefrontal lesions in monkeys. Brain Res (1978) 1.76
The acute effects of cannabinoids on memory in humans: a review. Psychopharmacology (Berl) (2006) 1.72
The relationship between non-acute adolescent cannabis use and cognition. Drug Alcohol Rev (2007) 1.62
Opposite effects of delta-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Neuropsychopharmacology (2009) 1.62
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users. J Psychopharmacol (2008) 1.60
Spatial working memory in heavy cannabis users: a functional magnetic resonance imaging study. Psychopharmacology (Berl) (2004) 1.56
Working memory performance in typically developing children and adolescents: behavioral evidence of protracted frontal lobe development. Dev Neuropsychol (2007) 1.54
Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology (2001) 1.53
Preserved working memory and altered brain activation in persons at risk for psychosis. Am J Psychiatry (2013) 1.52
Abstinent adolescent marijuana users show altered fMRI response during spatial working memory. Psychiatry Res (2008) 1.50
Cannabinoid tolerance and dependence: a review of studies in laboratory animals. Pharmacol Biochem Behav (2005) 1.49
Cannabis use and memory brain function in adolescent boys: a cross-sectional multicenter functional magnetic resonance imaging study. J Am Acad Child Adolesc Psychiatry (2010) 1.38
Verbal learning and memory in adolescent cannabis users, alcohol users and non-users. Psychopharmacology (Berl) (2011) 1.33
The residual neuropsychological effects of cannabis: the current status of research. Drug Alcohol Depend (1995) 1.32
Tolerance and cross-tolerance to neurocognitive effects of THC and alcohol in heavy cannabis users. Psychopharmacology (Berl) (2010) 1.22
Acute and residual effects of alcohol and marijuana, alone and in combination, on mood and performance. Psychopharmacology (Berl) (1994) 1.19
Cognitive function in schizophrenia. Int Clin Psychopharmacol (1997) 1.12
Functional development of the dorsolateral prefrontal cortex: an analysis utlizing reversible cryogenic depression. Brain Res (1978) 1.10
The influence of recency of use on fMRI response during spatial working memory in adolescent marijuana users. J Psychoactive Drugs (2010) 1.10
Acute effects of delta-9-tetrahydrocannabinol in rhesus monkeys as measured by performance in a battery of complex operant tests. J Pharmacol Exp Ther (1988) 1.09
Residual neuropsychologic effects of cannabis. Curr Psychiatry Rep (2001) 1.06
Differential effects of delta 9-THC on spatial reference and working memory in mice. Psychopharmacology (Berl) (2001) 1.04
Self-administration of cannabinoids by experimental animals and human marijuana smokers. Pharmacol Biochem Behav (2005) 1.01
Functional development of frontal association cortex in monkeys: behavioural and electrophysiological studies. Neurosci Res Program Bull (1982) 0.94
Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention. Neuropsychopharmacology (2004) 0.92
Acquisition and baseline performance of working memory tasks by adolescent rhesus monkeys. Brain Res (2011) 0.89
Chronic marijuana smoke exposure in the rhesus monkey. II: Effects on progressive ratio and conditioned position responding. J Pharmacol Exp Ther (1992) 0.89
Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cereb Cortex (2009) 0.87
Delay- and dose-dependent effects of Δ⁹-tetrahydrocannabinol administration on spatial and object working memory tasks in adolescent rhesus monkeys. Neuropsychopharmacology (2012) 0.85
Maturation of prefrontal cortex in the monkey revealed by local reversible cryogenic depression. Nature (1977) 0.84
Cannabis--1988. Acta Psychiatr Scand Suppl (1988) 0.83
A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci (2009) 21.94
Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat Rev Neurosci (2008) 8.14
Selective elimination of glutamatergic synapses on striatopallidal neurons in Parkinson disease models. Nat Neurosci (2006) 4.98
A toolbox of Cre-dependent optogenetic transgenic mice for light-induced activation and silencing. Nat Neurosci (2012) 4.87
Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci (2003) 4.86
The future of psychiatry as clinical neuroscience. Acad Med (2009) 3.31
Evaluation of a cervicography-based program to ensure quality of visual inspection of the cervix in HIV-infected women in Johannesburg, South Africa. J Low Genit Tract Dis (2015) 3.30
Synchronized delta oscillations correlate with the resting-state functional MRI signal. Proc Natl Acad Sci U S A (2007) 3.22
Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry (2008) 3.16
Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol (2006) 2.93
GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull (2008) 2.81
The effect of genital tract infections on HIV-1 shedding in the genital tract: a systematic review and meta-analysis. Sex Transm Dis (2008) 2.76
New insights into the classification and nomenclature of cortical GABAergic interneurons. Nat Rev Neurosci (2013) 2.65
Meeting the public health challenge of multidrug- and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther (2009) 2.53
Lower expression of glutamic acid decarboxylase 67 in the prefrontal cortex in schizophrenia: contribution of altered regulation by Zif268. Am J Psychiatry (2014) 2.46
Whole-genome analysis of diverse Chlamydia trachomatis strains identifies phylogenetic relationships masked by current clinical typing. Nat Genet (2012) 2.44
The initial field trials of DSM-5: new blooms and old thorns. Am J Psychiatry (2013) 2.39
The influence of chronic exposure to antipsychotic medications on brain size before and after tissue fixation: a comparison of haloperidol and olanzapine in macaque monkeys. Neuropsychopharmacology (2005) 2.37
Conflict of interest. Am J Psychiatry (2006) 2.30
Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci (2005) 2.18
A molecular signature of depression in the amygdala. Am J Psychiatry (2009) 2.18
Molecular evidence for increased expression of genes related to immune and chaperone function in the prefrontal cortex in schizophrenia. Biol Psychiatry (2007) 2.12
Association of nicotine addiction and nicotine's actions with separate cingulate cortex functional circuits. Arch Gen Psychiatry (2009) 2.03
Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Res (2013) 1.96
Reduced dendritic spine density in auditory cortex of subjects with schizophrenia. Neuropsychopharmacology (2008) 1.93
Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry (2011) 1.91
The influence of carbon dioxide on brain activity and metabolism in conscious humans. J Cereb Blood Flow Metab (2010) 1.88
Rat brains also have a default mode network. Proc Natl Acad Sci U S A (2012) 1.87
Alterations of cortical GABA neurons and network oscillations in schizophrenia. Curr Psychiatry Rep (2010) 1.87
Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex (2006) 1.85
Validation of cervical cancer screening methods in HIV positive women from Johannesburg South Africa. PLoS One (2013) 1.83
Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J Neurosci (2002) 1.79
Reciprocal alterations in pre- and postsynaptic inhibitory markers at chandelier cell inputs to pyramidal neurons in schizophrenia. Cereb Cortex (2002) 1.77
Association and linkage analyses of RGS4 polymorphisms in schizophrenia. Hum Mol Genet (2002) 1.68
Critical appraisal of DNA microarrays in psychiatric genomics. Biol Psychiatry (2006) 1.66
Neural and behavioral substrates of mood and mood regulation. Biol Psychiatry (2002) 1.65
Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Arch Gen Psychiatry (2008) 1.64
Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex (2008) 1.61
Lamina-specific reductions in dendritic spine density in the prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2005) 1.61
Protracted developmental trajectories of GABAA receptor alpha1 and alpha2 subunit expression in primate prefrontal cortex. Biol Psychiatry (2009) 1.58
NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull (2012) 1.57
Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry (2007) 1.57
Reduced pyramidal cell somal volume in auditory association cortex of subjects with schizophrenia. Neuropsychopharmacology (2002) 1.55
Efficacy, safety and tolerability of bosentan in Chinese patients with pulmonary arterial hypertension. J Heart Lung Transplant (2010) 1.54
Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa. Cancer Causes Control (2009) 1.52
The generic enhancement of photochromic dye switching speeds in a rigid polymer matrix. Nat Mater (2005) 1.52
GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Neural Plast (2011) 1.51
A neonatal ventral hippocampal lesion causes functional deficits in adult prefrontal cortical interneurons. J Neurosci (2008) 1.51
Cephalosporin MIC creep among gonococci: time for a pharmacodynamic rethink? J Antimicrob Chemother (2010) 1.48
Anatomical evidence of impaired feedforward auditory processing in schizophrenia. Biol Psychiatry (2006) 1.47
Conflict of interest, round 2. Am J Psychiatry (2006) 1.44
Pyramidal cell size reduction in schizophrenia: evidence for involvement of auditory feedforward circuits. Biol Psychiatry (2004) 1.43
Adenylate cyclase 7 is implicated in the biology of depression and modulation of affective neural circuitry. Biol Psychiatry (2012) 1.43
Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction. Physiol Behav (2002) 1.40
Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. Am J Psychiatry (2012) 1.40
GABA-related transcripts in the dorsolateral prefrontal cortex in mood disorders. Int J Neuropsychopharmacol (2011) 1.38
Amygdala gene expression correlates of social behavior in monkeys experiencing maternal separation. J Neurosci (2007) 1.35
Functional properties of fast spiking interneurons and their synaptic connections with pyramidal cells in primate dorsolateral prefrontal cortex. J Neurophysiol (2004) 1.35
Intrinsic resting-state activity predicts working memory brain activation and behavioral performance. Hum Brain Mapp (2012) 1.35
Making the case for a candidate vulnerability gene in schizophrenia: Convergent evidence for regulator of G-protein signaling 4 (RGS4). Biol Psychiatry (2006) 1.34
Mapping auditory core, lateral belt, and parabelt cortices in the human superior temporal gyrus. J Comp Neurol (2005) 1.34
Interneuron diversity in layers 2-3 of monkey prefrontal cortex. Cereb Cortex (2008) 1.33
Postsynaptic diacylglycerol lipase mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex. J Physiol (2011) 1.32
Role of the carboxyl terminal of connexin43 in transjunctional fast voltage gating. Circ Res (2002) 1.32
Primate trace amine receptor 1 modulation by the dopamine transporter. J Pharmacol Exp Ther (2005) 1.31
Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci (2011) 1.30
Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry (2010) 1.30
Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. Cereb Cortex (2010) 1.30
Postnatal development of pre- and postsynaptic GABA markers at chandelier cell connections with pyramidal neurons in monkey prefrontal cortex. J Comp Neurol (2003) 1.29
Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry (2012) 1.28
Functional maturation of excitatory synapses in layer 3 pyramidal neurons during postnatal development of the primate prefrontal cortex. Cereb Cortex (2007) 1.27
Frequency specificity of functional connectivity in brain networks. Neuroimage (2008) 1.26
Cluster analysis-based physiological classification and morphological properties of inhibitory neurons in layers 2-3 of monkey dorsolateral prefrontal cortex. J Neurophysiol (2005) 1.23
Cortical basket cell dysfunction in schizophrenia. J Physiol (2012) 1.22
Conserved interneuron-specific ErbB4 expression in frontal cortex of rodents, monkeys, and humans: implications for schizophrenia. Biol Psychiatry (2011) 1.22
Neuropathologic correlates of late-onset major depression. Neuropsychopharmacology (2004) 1.21
Prefrontal cortical circuits in schizophrenia. Curr Top Behav Neurosci (2010) 1.20
Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology (2006) 1.20
Postnatal developmental trajectories of neural circuits in the primate prefrontal cortex: identifying sensitive periods for vulnerability to schizophrenia. Schizophr Bull (2011) 1.20
Altered markers of tonic inhibition in the dorsolateral prefrontal cortex of subjects with schizophrenia. Am J Psychiatry (2009) 1.18
Dopamine increases inhibition in the monkey dorsolateral prefrontal cortex through cell type-specific modulation of interneurons. Cereb Cortex (2006) 1.17
Simultaneous perfusion and BOLD imaging using reverse spiral scanning at 3T: characterization of functional contrast and susceptibility artifacts. Magn Reson Med (2002) 1.16
The intron 5/6 promoter region of the ship1 gene regulates expression in stem/progenitor cells of the mouse embryo. Dev Biol (2005) 1.16
Implicit reference-based group-wise image registration and its application to structural and functional MRI. Neuroimage (2009) 1.16
Selective pyramidal cell reduction of GABA(A) receptor α1 subunit messenger RNA expression in schizophrenia. Neuropsychopharmacology (2011) 1.15
Postnatal development of parvalbumin- and GABA transporter-immunoreactive axon terminals in monkey prefrontal cortex. J Comp Neurol (2002) 1.15
Altered cortical CDC42 signaling pathways in schizophrenia: implications for dendritic spine deficits. Biol Psychiatry (2010) 1.14